Patents Assigned to Borean Pharma A/S
  • Multimerised HIV fusion inhibitors
    Publication number: 20050202043
    Abstract: There are provided multimeric fusion proteins exhibiting anti-viral activity. The fusion proteins comprise the HR2 region of the ectodomain of the human immunodeficiency virus gp41 protein which is fused to a multimerisation domain peptide such as a trimerisation domain derived from tetranectin. The multimerised fusion proteins may be used as HIV fusion inhibitors in the treatment of AIDS.
    Type: Application
    Filed: February 23, 2005
    Publication date: September 15, 2005
    Applicant: Borean Pharma A/S
    Inventor: Michael Etzerodt